Answers are grounded in this paper and cite their sources.
One‐carbon metabolism, which is dependent on folate, plays a critical role in central nervous system (CNS) development and neurogenesis by regulating nucleotide synthesis, epigenetic methylation, neurotransmission, mitochondrial bioenergetics, and redox balance. Disrupted cerebral folate transport due to folate receptor alpha (FRα) autoantibodies, genetic variants affecting folate metabolism, or impaired transport across the choroid plexus and blood–brain barrier can cause cerebral folate deficiency (CFD), increasingly associated with autism spectrum disorder (ASD). Reduced CNS folate availability may impair methylation, alter monoamine and glutamate signaling, disrupt mitochondrial one‐carbon metabolism, and increase neuronal oxidative stress. Folinic acid (leucovorin), a reduced folate derivative, may bypass certain transport and metabolic limitations, replenishing cellular folate stores and supporting CNS function. It may also support mitochondrial redox homeostasis, glutathione‐dependent antioxidant defenses, and metabolic coupling between cytosolic and mitochondrial one‐carbon pathways. Clinical trials have reported improvements in language, communication, and adaptive behavior, particularly among FRα autoantibody‐positive ASD subgroups. This review integrates evidence on folate transport, genetic susceptibility, mitochondrial metabolism, and gut–brain interactions to explore cerebral folate dysregulation in ASD pathophysiology. From an interorgan communication perspective, cerebral folate homeostasis depends on coordinated intestinal absorption, systemic folate circulation, choroid plexus transport, and neuronal metabolism. Gut‐derived microbial metabolites may influence peripheral‐central metabolic signaling, although their direct contribution to cerebral folate availability remains uncertain. Understanding these interconnected pathways may support biomarker‐guided folinic acid interventions and advance precision therapeutic strategies for biologically defined ASD subgroups while identifying important mechanistic and clinical research priorities.
No takes yet. Share an insight, caveat, or question.
Iyer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: